# Bioequivalence Study of One Tablet of Paracetamol 1000 mg + Codeine 30 mg vs. Two Tablets of Paracetamol 500 mg + Codeine 30 mg

> **NCT02902666** · PHASE1 · COMPLETED · sponsor: **Aziende Chimiche Riunite Angelini Francesco S.p.A** · enrollment: 46 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Paracetamol 1000 mg/codeine phosphate hemihydrate 30 mg tablet
- **DRUG:** Paracetamol 500 mg/codeine phosphate hemihydrate 30 mg tablet

## Key facts

- **NCT ID:** NCT02902666
- **Lead sponsor:** Aziende Chimiche Riunite Angelini Francesco S.p.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2016-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02902666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02902666, "Bioequivalence Study of One Tablet of Paracetamol 1000 mg + Codeine 30 mg vs. Two Tablets of Paracetamol 500 mg + Codeine 30 mg". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02902666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*